Allorion

Allorion Therapeutics

This biopharmaceutical company develops small-molecule therapies for cancer and autoimmune diseases to serve patients and global pharmaceutical partners.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

ALLOX

This company develops a computational and experimental platform to identify allosteric sites in proteins for pharmaceutical companies and researchers to design new drugs.

Graviton Bioscience Corporation

The company develops small-molecule therapeutics targeting autoimmune, fibrotic and central nervous system diseases for patients with unmet medical needs.

Orogen Therapeutics

Orogen Therapeutics develops small-molecule drugs for autoimmune and immuno-inflammatory diseases using an AI-enabled DNA-encoded library platform to identify novel chemical matter for patients.

BlossomHill Therapeutics

This biopharmaceutical company develops small molecule medicines to treat patients with various forms of cancer and autoimmune disorders.

Biopharmaceutical company

This firm develops small molecule drugs targeting protein regulatory sites to treat patients with cancer and autoimmune diseases.

AllInBio

The company develops precision immunology therapies to identify and treat patients genetically predisposed to chronic inflammatory and autoimmune diseases.